MARKET DEFINITION

To identify illness, the medical Speciality of anatomic pathology examines organs and tissues under microscopic, macroscopic, biochemical, immunologic, and molecular microscopes. From an ancient study of entire bodies (autopsy) to contemporary procedures needed for cancer diagnosis and prognosis to inform therapeutic decision-making in oncology, surgical pathology has undergone a significant evolution in recent years. One of the two subspecialties of pathology, the other being clinical pathology, which deals with the diagnosis of disease through the laboratory examination of body fluids or tissues, is anatomical. Pathologists frequently combine anatomical pathology with clinical pathology, a discipline known as general pathology. In veterinary pathology, there are related specialties.

MARKET DYNAMICS 

One of the major factors driving the market's growth is the high prevalence of target disorders, including cancer, as well as the increased emphasis on the implementation of advanced pathology equipment. Furthermore, by 2020, cancer will be the second greatest cause of death worldwide, killing 10 million people. About one-sixth of all fatalities globally are caused by cancer. 19.3 million new instances of cancer were reported in 2020, and by 2040, that figure is projected to reach 30.2 million. The expanding elderly population as well as the general population might be blamed for the rise in cancer incidence. Owing to these factors they are expected to fuel the market growth. In addition, the accessibility of used anatomic pathology equipment poses a significant barrier to this market's expansion. Rankin Biomedical Corporation, LabX, AL-TAR, and Swerdlick Medical Systems are a few businesses that sell reconditioned anatomic pathology equipment such as tissue processors, staining systems, and microtomes hinder market growth.

REPORT SCOPE

The report titled “Global Anatomic Pathology Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Anatomic Pathology market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Anatomic Pathology market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Anatomic Pathology Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION  

The Global Anatomic Pathology Market is segmented based on Product, Services, Application End-Users, and region. Based on Product, the market has been segmented into Instrument, Consumables, Antibodies, and Others, whereas based on Services, the market comprises Histopathology, Cytopathology, and Others. Based on Application, the market has been segmented into Disease Diagnosis, Drug Discovery & Development, and Others, whereas, the End-User segmentation includes Pathology Labs, Research Institutes, Hospitals, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Anatomic Pathology market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Anatomic Pathology market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Anatomic Pathology market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Anatomic Pathology industry in the past three years.

Key players in the Global Anatomic Pathology Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Hoffmann-La Roche AG
• Danaher Corporation
• PHC Holdings Corporation
• Dickson and Company
• Abcam plc.
• Hologic, Inc.
• Agilent Technologies
• Merck KGaA
• Sakura Finetek
• Bio SB
• BioGenex
• Milestone Medical

COVID-19 IMPACT ANALYSIS ON GLOBAL ANATOMIC PATHOLOGY MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Anatomic Pathology market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Anatomic Pathology market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Anatomic Pathology market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Application
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Product Trends
3.2.2. Services Trends
3.2.3. Application Trends
3.2.4. End-User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Anatomic Pathology Market
3.6. COVID-19 Impact Assessment in Anatomic Pathology Market
3.6.1. Impact Assessment on Global Anatomic Pathology Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
4.1. Global Anatomic Pathology Market Share, By Product, 2017 - 2028 (USD Million)
4.1.1. Instrument
4.1.2. Consumables
4.1.3. Antibodies
4.1.4. Others

Chapter 5. Global Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
5.1. Global Anatomic Pathology Market Share, By Services, 2017 - 2028 (USD Million)
5.1.1. Histopathology
5.1.2. Cytopathology
5.1.3. Others

Chapter 6. Global Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
6.1. Global Anatomic Pathology Market Share, By Application, 2017 - 2028 (USD Million)
6.1.1. Disease Diagnosis
6.1.2. Drug Discovery & Development
6.1.3. Others

Chapter 7. Global Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
7.1. Global Anatomic Pathology Market Share, By End-User, 2017 - 2028 (USD Million)
7.1.1. Pathology Labs
7.1.2. Research Institutes
7.1.3. Hospitals
7.1.4. Others

Chapter 8. Global Anatomic Pathology Market Overview, By Geography, 2017 - 2028 (USD Million)
8.1. Global Anatomic Pathology Market Share, By Geography, 2017 - 2028 (USD Million)
8.1.1. Market Size and Projections, by Countries, 2017 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 9. North America Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. North America Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market size and projections, 2017 - 2028 (USD Million)
9.1.2. North America Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
9.1.3. North America Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
9.1.4. North America Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
9.1.5. North America Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2. North America Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. U.S. Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. U.S. Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
9.2.1.2. U.S. Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
9.2.1.3. U.S. Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.1.4. U.S. Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.2. Canada Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Canada Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
9.2.2.2. Canada Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
9.2.2.3. Canada Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.2.4. Canada Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.3. Mexico Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Mexico Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
9.2.3.2. Mexico Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
9.2.3.3. Mexico Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.3.4. Mexico Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 10. Europe Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Europe Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market size and projections, 2017 - 2028 (USD Million)
10.1.2. Europe Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.1.3. Europe Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.1.4. Europe Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.1.5. Europe Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2. Europe Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Germany Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Germany Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.1.2. Germany Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.1.3. Germany Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.1.4. Germany Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.2. France Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. France Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.2.2. France Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.2.3. France Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.2.4. France Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.3. UK Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. UK Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.3.2. UK Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.3.3. UK Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.3.4. UK Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.4. Italy Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. Italy Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.4.2. Italy Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.4.3. Italy Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.4.4. Italy Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.5. Spain Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. Spain Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.5.2. Spain Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.5.3. Spain Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.5.4. Spain Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.6. NORDIC Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. NORDIC Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.6.2. NORDIC Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.6.3. NORDIC Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.6.4. NORDIC Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.7. Russia and CIS Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Russia and CIS Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.7.2. Russia and CIS Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.7.3. Russia and CIS Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.7.4. Russia and CIS Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.8. Rest of Europe Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
10.2.8.1. Rest of Europe Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
10.2.8.2. Rest of Europe Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
10.2.8.3. Rest of Europe Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.8.4. Rest of Europe Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 11. Asia Pacific Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Asia Pacific Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market size and projections, 2017 - 2028 (USD Million)
11.1.2. Asia Pacific Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.1.3. Asia Pacific Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.1.4. Asia Pacific Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.1.5. Asia Pacific Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2. Asia Pacific Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. India Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. India Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.1.2. India Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.1.3. India Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.1.4. India Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.2. China Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. China Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.2.2. China Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.2.3. China Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.2.4. China Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.3. Japan Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Japan Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.3.2. Japan Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.3.3. Japan Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.3.4. Japan Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.4. ASEAN Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.4.1. ASEAN Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.4.2. ASEAN Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.4.3. ASEAN Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.4.4. ASEAN Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.5. South Korea Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.5.1. South Korea Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.5.2. South Korea Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.5.3. South Korea Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.5.4. South Korea Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.6. Australia Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.6.1. Australia Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.6.2. Australia Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.6.3. Australia Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.6.4. Australia Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.7. Rest of Asia Pacific Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
11.2.7.1. Rest of Asia Pacific Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
11.2.7.2. Rest of Asia Pacific Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
11.2.7.3. Rest of Asia Pacific Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.7.4. Rest of Asia Pacific Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 12. South America Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. South America Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market size and projections, 2017 - 2028 (USD Million)
12.1.2. South America Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
12.1.3. South America Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
12.1.4. South America Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
12.1.5. South America Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
12.2. South America Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. Brazil Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. Brazil Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
12.2.1.2. Brazil Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
12.2.1.3. Brazil Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.1.4. Brazil Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
12.2.2. Argentina Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. Argentina Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
12.2.2.2. Argentina Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
12.2.2.3. Argentina Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.2.4. Argentina Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
12.2.3. Rest of South America Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of South America Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
12.2.3.2. Rest of South America Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
12.2.3.3. Rest of South America Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.3.4. Rest of South America Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 13. Middle East & Africa Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
13.1. Middle East & Africa Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
13.1.1. Market size and projections, 2017 - 2028 (USD Million)
13.1.2. Middle East & Africa Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
13.1.3. Middle East & Africa Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
13.1.4. Middle East & Africa Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
13.1.5. Middle East & Africa Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
13.2. Middle East & Africa Anatomic Pathology Market Overview, By Countries, 2017 - 2028 (USD Million)
13.2.1. GCC Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
13.2.1.1. GCC Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
13.2.1.2. GCC Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
13.2.1.3. GCC Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.1.4. GCC Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
13.2.2. South Africa Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
13.2.2.1. South Africa Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
13.2.2.2. South Africa Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
13.2.2.3. South Africa Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.2.4. South Africa Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)
13.2.3. Rest of Middle East & Africa Anatomic Pathology Market Overview, 2017 - 2028 (USD Million)
13.2.3.1. Rest of Middle East & Africa Anatomic Pathology Market Overview, By Product, 2017 - 2028 (USD Million)
13.2.3.2. Rest of Middle East & Africa Anatomic Pathology Market Overview, By Services, 2017 - 2028 (USD Million)
13.2.3.3. Rest of Middle East & Africa Anatomic Pathology Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.3.4. Rest of Middle East & Africa Anatomic Pathology Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 14. Competitive Landscape
14.1. Competitive Environment, 2021
14.2. Strategic Framework
14.2.1. Partnership/Collaborations/Agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Product Development

Chapter 15. Key Vendor Analysis
15.1. F. Hoffmann-La Roche AG
15.1.1. Business Overview
15.1.2. Product Benchmarking
15.1.3. Financial Data
15.1.4. Strategic Overview
15.1.5. Key Developments
15.1.6. SWOT Analysis
15.2. Danaher Corporation
15.2.1. Business Overview
15.2.2. Product Benchmarking
15.2.3. Financial Data
15.2.4. Strategic Overview
15.2.5. Key Developments
15.2.6. SWOT Analysis
15.3. PHC Holdings Corporation.
15.3.1. Business Overview
15.3.2. Product Benchmarking
15.3.3. Financial Data
15.3.4. Strategic Overview
15.3.5. Key Developments
15.3.6. SWOT Analysis
15.4. Dickson and Company.
15.4.1. Business Overview
15.4.2. Product Benchmarking
15.4.3. Financial Data
15.4.4. Strategic Overview
15.4.5. Key Developments
15.4.6. SWOT Analysis
15.5. Abcam plc.
15.5.1. Business Overview
15.5.2. Product Benchmarking
15.5.3. Financial Data
15.5.4. Strategic Overview
15.5.5. Key Developments
15.5.6. SWOT Analysis
15.6. Hologic, Inc.
15.6.1. Business Overview
15.6.2. Product Benchmarking
15.6.3. Financial Data
15.6.4. Strategic Overview
15.6.5. Key Developments
15.6.6. SWOT Analysis
15.7. Agilent Technologies
15.7.1. Business Overview
15.7.2. Product Benchmarking
15.7.3. Financial Data
15.7.4. Strategic Overview
15.7.5. Key Developments
15.7.6. SWOT Analysis
15.8. Merck KGaA
15.8.1. Business Overview
15.8.2. Product Benchmarking
15.8.3. Financial Data
15.8.4. Strategic Overview
15.8.5. Key Developments
15.8.6. SWOT Analysis
15.9. Sakura Finetek
15.9.1. Business Overview
15.9.2. Product Benchmarking
15.9.3. Financial Data
15.9.4. Strategic Overview
15.9.5. Key Developments
15.9.6. SWOT Analysis
15.10. Bio SB
15.10.1. Business Overview
15.10.2. Product Benchmarking
15.10.3. Financial Data
15.10.4. Strategic Overview
15.10.5. Key Developments
15.10.6. SWOT Analysis
15.11. BioGenex
15.11.1. Business Overview
15.11.2. Product Benchmarking
15.11.3. Financial Data
15.11.4. Strategic Overview
15.11.5. Key Developments
15.11.6. SWOT Analysis
15.12. Milestone Medical
15.12.1. Business Overview
15.12.2. Product Benchmarking
15.12.3. Financial Data
15.12.4. Strategic Overview
15.12.5. Key Developments
15.12.6. SWOT Analysis

Chapter 16. Future Outlook of the Market